Domestically produced COVID-19 vaccine approved
Health Minister Saeed Namaki announced that the COVIRAN/ Barekat Coronavirus vaccine, had received approval for public inoculations.
He said that Iran had gone through nearly a year of intensive work to join the Club of countries with the capacity to scale up production for Coronavirus vaccines.
COVIRAN/Barekat was unveiled on 29 December 2020 with mass production beginning on March 29th.
It has been developed by Shifa Pharmed, a subsidiary of the Iranian economic and industrial conglomerate, Setad.
Production capacity is slated to reach 12 to 15 million doses per month by the end of the summer.
Iran is among the first countries which started developing a vaccine against the Coronavirus and now four companies are endeavoring to release their products by September, and inoculate the general population.
Iran hopes that domestic initiatives could significantly boost vaccine supplies for the nationwide inoculation program which started last year.